Capital World Investors - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 1 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Capital World Investors ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$13,700,980
-28.9%
683,0000.0%0.00%
-25.0%
Q2 2023$19,267,430
+64.0%
683,0000.0%0.00%
+100.0%
Q1 2023$11,747,600
-14.6%
683,0000.0%0.00%
-33.3%
Q4 2022$13,755,620
-7.0%
683,0000.0%0.00%0.0%
Q3 2022$14,794,000
-22.9%
683,0000.0%0.00%
-25.0%
Q2 2022$19,192,000
-39.1%
683,0000.0%0.00%
-20.0%
Q1 2022$31,514,000
-45.1%
683,0000.0%0.01%
-44.4%
Q4 2021$57,413,000
+26.1%
683,0000.0%0.01%
+12.5%
Q3 2021$45,515,000
+27.7%
683,000
+1.9%
0.01%
+33.3%
Q2 2021$35,644,000
+122.0%
670,000
+81.1%
0.01%
+100.0%
Q1 2021$16,054,000
-63.6%
370,000
-56.5%
0.00%
-66.7%
Q4 2020$44,149,000
+103.4%
850,000
+28.0%
0.01%
+80.0%
Q3 2020$21,706,000
+0.4%
664,000
+47.6%
0.01%0.0%
Q2 2020$21,609,000450,0000.01%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Decheng Capital Management III (Cayman), LLC 2,099,583$42,117,63514.06%
Mayo Clinic 187,143$3,754,0897.23%
Matrix Capital Management Company, LP 13,959,973$280,037,0583.36%
5AM Venture Management, LLC 490,000$9,829,4002.83%
Eventide Asset Management 7,814,039$156,749,6222.82%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 961,486$19,287,4102.70%
Avidity Partners Management LP 2,100,000$42,126,0001.70%
First Light Asset Management, LLC 848,477$17,020,4491.62%
Sofinnova Investments, Inc. 1,211,641$24,305,5181.53%
SECTORAL ASSET MANAGEMENT INC 386,525$7,753,6921.51%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders